Curative Biosciences Inc. (CBDX)
OTC PINK OTC PINK Primary Summary
CBDX Chart
Curative Biosciences Inc. (CBDX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Curative Biosciences Inc. ever had a stock split?
Curative Biosciences Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Marcel Gamma CEO | OTC PINK Exchange | 23127M101 CUSIP |
| US Country | 6 Employees | - Last Dividend | 1 Oct 2012 Last Split | - IPO Date |
Overview
Curative Biosciences, Inc. is a company engaged in the development and commercialization of therapeutic products derived from hemp, specifically focusing on Cannabidiol (CBD). Initially founded as Amaize Beverage Corporation, the company underwent a significant rebranding and shift in focus, adopting its current name in August 2017 to better reflect its dedication to creating curative therapeutics. Since its inception in 2009, Curative Biosciences has been headquartered in Miami, Florida, illustrating a strong commitment to leveraging natural health products and the medical cannabis industry to address a variety of health issues. Through its innovative approach, the company aims to harness the therapeutic potential of hemp-derived CBD, providing an alternative and natural health solution to consumers and patients.
Products and Services
- Hemp-derived Cannabidiol (CBD) Therapeutics
At the core of Curative Biosciences' product line are its hemp-derived CBD therapeutics, designed to offer a natural alternative for managing various health conditions. Focusing on the medicinal properties of Cannabidiol, these products aim to leverage the anti-inflammatory, analgesic, and neuroprotective effects of CBD to benefit users with conditions that may respond to these properties.
- Natural Health Products
In addition to its focus on CBD-based therapeutics, Curative Biosciences is also committed to the development and marketing of a wider range of natural health products. This diversification strategy enables the company to cater to a broader audience seeking holistic and natural solutions for their health and wellness needs. These products encompass a variety of dietary supplements and natural remedies formulated to support overall health and well-being.
- Medical Cannabis Industry Operations
Recognizing the burgeoning potential of the medical cannabis sector, Curative Biosciences is actively involved in operations within this industry. This includes not only the research and development of cannabis-based therapeutics but also efforts to understand and navigate the regulatory, production, and marketing challenges associated with medical cannabis. Their involvement in this sector underscores the company's commitment to exploring all avenues of natural therapeutic development.
